Track the 에스바이오메딕스 share price and the full insider trade history of the company, a listed issuer based in South Korea. Shares are listed on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 에스바이오메딕스 has published 28 insider filings. Market capitalisation: €389.5bn. The latest transaction was reported on 16 March 2026 (Other). Among the most active insiders: KANG SAEIL. All data is accessible without an account.
28
Insider Decl.
0
Thresholds
·
10 ops.
Buy Volume
·
10 ops.
Sell Volume
22Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 22,768 of 26,213 companies
25.0
score / 100
Value
25
Quality
25
FCF yld-3.4%
Earn yld-3.3%
EV/EBITDA·
ROE-41%
Gross mgn46%
Net mgn-49%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.